HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heinz Ludwig Selected Research

Filgrastim (Neupogen)

6/2019Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study.
3/2019Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study.
1/2017Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study).
1/2017Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study.
2/2016Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).
1/2016Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).
3/2011Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments.
3/2011Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heinz Ludwig Research Topics

Disease

91Multiple Myeloma
02/2022 - 01/2002
52Neoplasms (Cancer)
01/2022 - 06/2002
26Anemia
01/2018 - 01/2002
11Disease Progression
10/2018 - 12/2007
7Bone Diseases (Bone Disease)
01/2019 - 12/2003
6Renal Insufficiency (Renal Failure)
10/2019 - 10/2007
6Chemotherapy-Induced Febrile Neutropenia
06/2019 - 03/2011
5Infections
02/2022 - 09/2014
5Febrile Neutropenia
06/2019 - 03/2011
5Thrombocytopenia (Thrombopenia)
01/2018 - 01/2006
4Pain (Aches)
01/2022 - 12/2007
4Neutropenia
06/2019 - 01/2017
4Hematologic Neoplasms (Hematological Malignancy)
03/2019 - 06/2002
4Fatigue
01/2018 - 06/2002
4Peripheral Nervous System Diseases (PNS Diseases)
10/2017 - 01/2006
4Iron Deficiencies
12/2015 - 01/2014
3Lymphoma (Lymphomas)
01/2020 - 11/2005
3Nausea
01/2018 - 11/2005
3Leukemia
03/2016 - 11/2005
2Residual Neoplasm
06/2020 - 01/2020
2Vomiting
01/2018 - 11/2005
2Pneumonia (Pneumonitis)
10/2017 - 01/2016
2Hypertension (High Blood Pressure)
10/2017 - 01/2016
2Chronic Disease (Chronic Diseases)
01/2017 - 04/2004
2Monoclonal Gammopathy of Undetermined Significance
03/2016 - 06/2014
2Breast Neoplasms (Breast Cancer)
11/2014 - 02/2009
2Thromboembolism
06/2011 - 04/2008
2Acute Kidney Injury (Acute Renal Failure)
10/2010 - 10/2007
2Constipation
09/2010 - 08/2010
2Colorectal Neoplasms (Colorectal Cancer)
02/2009 - 01/2006
2Hodgkin Disease (Hodgkin's Disease)
10/2008 - 11/2006
2Second Primary Neoplasms (Neoplasms, Second)
02/2007 - 06/2002
1Plasmacytoma
06/2020
1Frailty
01/2020
1COVID-19
01/2020
1Thrombotic Microangiopathies
01/2019

Drug/Important Bio-Agent (IBA)

34Dexamethasone (Maxidex)FDA LinkGeneric
06/2020 - 11/2005
29Bortezomib (Velcade)FDA Link
06/2020 - 11/2005
27Lenalidomide (CC 5013)FDA Link
11/2021 - 03/2009
18Thalidomide (Thalomid)FDA Link
01/2020 - 12/2002
17carfilzomibIBA
11/2020 - 09/2012
16Hemoglobins (Hemoglobin)IBA
01/2018 - 01/2002
12Proteasome InhibitorsIBA
01/2021 - 11/2005
10HematinicsIBA
12/2014 - 02/2008
8Proteins (Proteins, Gene)FDA Link
12/2020 - 12/2005
8Filgrastim (Neupogen)FDA Link
06/2019 - 03/2011
8Biosimilar PharmaceuticalsIBA
06/2019 - 03/2011
7Pharmaceutical PreparationsIBA
10/2021 - 03/2009
6Melphalan (Alkeran)FDA LinkGeneric
06/2020 - 11/2005
5Immunomodulating AgentsIBA
01/2018 - 11/2010
5IronIBA
12/2015 - 01/2014
5Darbepoetin alfa (Aranesp)FDA Link
09/2012 - 05/2004
4CreatinineIBA
01/2016 - 05/2010
4ErythropoietinFDA Link
01/2009 - 01/2004
4PlatinumIBA
03/2007 - 01/2006
3Immunoglobulins (Immunoglobulin)IBA
02/2022 - 03/2016
3Prednisone (Sone)FDA LinkGeneric
06/2020 - 11/2005
3ixazomibIBA
01/2020 - 01/2017
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018 - 05/2010
3Diphosphonates (Bisphosphonates)IBA
03/2016 - 12/2007
3CytokinesIBA
12/2015 - 01/2005
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 11/2005
3Biological ProductsIBA
06/2014 - 01/2004
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2010 - 11/2005
3Prednisolone (Predate)FDA LinkGeneric
09/2010 - 11/2005
2Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2017
2PanobinostatIBA
07/2018 - 01/2018
2Histone Deacetylase InhibitorsIBA
01/2018 - 01/2014
2ParaproteinsIBA
11/2017 - 10/2007
2Monoclonal AntibodiesIBA
01/2017 - 05/2016
2Ferritins (Ferritin)IBA
12/2014 - 11/2014
2Immunoglobulin G (IgG)IBA
06/2014 - 05/2010
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2011 - 06/2002
2Radioisotopes (Radionuclides)IBA
01/2011 - 02/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2009 - 12/2007
2ibritumomab tiuxetan (Zevalin)FDA Link
02/2009 - 10/2008
2Epoetin Alfa (Epogen)FDA Link
01/2004 - 06/2002
1VaccinesIBA
12/2021
1HIV Protease InhibitorsIBA
01/2021
1LipidsIBA
01/2021
1Membrane LipidsIBA
01/2021
1Nelfinavir (Viracept)FDA Link
01/2021
1PTC-028IBA
01/2020
1vasectrin IIIIBA
01/2020
1Guanosine Diphosphate (GDP)IBA
01/2020
1PTC596IBA
01/2020
1ametantrone (HAQ)IBA
01/2020
1daratumumabIBA
01/2020
1Chimeric Antigen ReceptorsIBA
12/2019
1plitidepsin (aplidine)IBA
09/2019
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2019

Therapy/Procedure

49Therapeutics
02/2022 - 01/2002
29Drug Therapy (Chemotherapy)
06/2020 - 01/2004
8Radiotherapy
11/2018 - 01/2004
7Stem Cell Transplantation
06/2020 - 08/2009
3Transplantation
12/2015 - 07/2012
2Aftercare (After-Treatment)
11/2016 - 09/2012
2Autologous Transplantation
11/2014 - 07/2012
1Precision Medicine
12/2020
1Blood Component Removal (Apheresis)
01/2020